This is because the abdomen generally has higher blood flow to the subcutaneous tissue, pulling medication into systemic circulation faster
Physicians may prescribe compounded medications as needed to meet patient requirements or drug shortages
Safety advantage: Unlike HGH, AOD-9604 does not significantly impact IGF-1, insulin sensitivity, or blood sugar regulation Therapeutic potential: Initially investigated as an anti-obesity drug, it has since gained attention in the wellness and peptide therapy communities for weight loss and metabolic health
As this product contains benzyl alcohol, it should not be used in newborns or in people who are sensitive to benzyl alcohol
Available at: Hartman TJ, Woodson K, Stolzenberg-Solomon R, et al